Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 2Weight Loss 1Patient Compliance 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Bevacizumab 233Fluorouracil 219Oxaliplatin 215Irinotecan 215Leucovorin 198Capecitabine 153Cetuximab 145Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15apatinib 14Gemcitabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × Diet × Clear all
NCT01708824 2016-05-12

Diet and Physical Activity Intervention in CRC Survivors

The University of Hong Kong

Phase 2 Unknown
224 enrolled
Gastrointestinal

Motor Activity, Patient Compliance, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡